-
[show abstract]
[hide abstract]
ABSTRACT: MicroRNAs are critical mediators of stem cell pluripotency, differentiation, and malignancy. Limited information exists regarding microRNA alterations that facilitate initiation and progression of human lung cancers. In this study, array techniques were used to evaluate microRNA expression in normal human respiratory epithelia and lung cancer cells cultured in the presence or absence of cigarette smoke condensate (CSC). Under relevant exposure conditions, CSC significantly repressed miR-487b. Subsequent experiments demonstrated that miR-487b directly targeted SUZ12, BMI1, WNT5A, MYC, and KRAS. Repression of miR-487b correlated with overexpression of these targets in primary lung cancers and coincided with DNA methylation, de novo nucleosome occupancy, and decreased H2AZ and TCF1 levels within the miR-487b genomic locus. Deoxy-azacytidine derepressed miR-487b and attenuated CSC-mediated silencing of miR-487b. Constitutive expression of miR-487b abrogated Wnt signaling, inhibited in vitro proliferation and invasion of lung cancer cells mediated by CSC or overexpression of miR-487b targets, and decreased growth and metastatic potential of lung cancer cells in vivo. Collectively, these findings indicate that miR-487b is a tumor suppressor microRNA silenced by epigenetic mechanisms during tobacco-induced pulmonary carcinogenesis and suggest that DNA demethylating agents may be useful for activating miR-487b for lung cancer therapy.
The Journal of clinical investigation 03/2013; 123(3):1241-61. · 15.39 Impact Factor
-
Mary Zhang,
Aarti Mathur,
Yuwei Zhang,
Sichuan Xi,
Scott Atay,
Julie A Hong,
Nicole Datrice,
Trevor Upham,
Clinton D Kemp,
R Taylor Ripley,
Gordon Wiegand,
Itzak Avital,
Patricia Fetsch,
Haresh Mani,
Daniel Zlott,
Robert Robey,
Susan E Bates,
Xinmin Li,
Mahadev Rao,
David S Schrump
[show abstract]
[hide abstract]
ABSTRACT: Cigarette smoking at diagnosis or during therapy correlates with poor outcome in patients with lung and esophageal cancers, yet the underlying mechanisms remain unknown. In this study, we observed that exposure of esophageal cancer cells to cigarette smoke condensate (CSC) led to upregulation of the xenobiotic pump ABCG2, which is expressed in cancer stem cells and confers treatment resistance in lung and esophageal carcinomas. Furthermore, CSC increased the side population of lung cancer cells containing cancer stem cells. Upregulation of ABCG2 coincided with increased occupancy of aryl hydrocarbon receptor, Sp1, and Nrf2 within the ABCG2 promoter, and deletion of xenobiotic response elements and/or Sp1 sites markedly attenuated ABCG2 induction. Under conditions potentially achievable in clinical settings, mithramycin diminished basal as well as CSC-mediated increases in AhR, Sp1, and Nrf2 levels within the ABCG2 promoter, markedly downregulated ABCG2, and inhibited proliferation and tumorigenicity of lung and esophageal cancer cells. Microarray analyses revealed that mithramycin targeted multiple stem cell-related pathways in vitro and in vivo. Collectively, our findings provide a potential mechanistic link between smoking status and outcome of patients with lung and esophageal cancers, and support clinical use of mithramycin for repressing ABCG2 and inhibiting stem cell signaling in thoracic malignancies.
Cancer Research 07/2012; 72(16):4178-92. · 7.86 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: In recent years, the emergence and reemergence of infectious viral diseases has promoted intense research to explore new approaches for drug development. Targeting of a specific viral gene to inhibit viral replication is one of the newly developing strategies of experimental research. In this regard, nucleic acid (NA)-based antiviral agents, such as ribozymes, antisense oligonucleotides, aptamers, short interfering RNA, MicroRNAs (miRNAs), and artificial miRNAs (AmiRNAs), represent a new collection of potential gene targeting tools. These therapeutic sequences can be designed to target the viral genome or messenger RNAs (mRNAs), leading to down regulation of a specific viral gene. Cellular miRNAs and DNA virus-encoded miRNAs play important roles in viral replication and pathogenesis. Thus, silencing of these miRNAs using specific inhibitors, such as antagomirs or miRNA sponges, is another promising strategy for inhibition of viral replication. AmiRNAs are mimics of endogenous miRNAs, which can be designed to target viral mRNAs and inhibit viral infection with mutational tolerance. The NA-based antiviral strategy has been applied experimentally to inhibit many RNA and DNA viruses, such as the highly pathogenic avian influenza (H5N1), SARSCoV, Hepatitis C virus (HCV), and Hepatitis B virus (HBV).
This strategy has many advantages, particularly the drug specificity and high affinity to the viral gene targets. Here, we highlight current research progress in the field of viral gene targeting in regards to several viral diseases of both human and animal origin. Additionally, we discussed the limitations and pitfalls that pertain to this new class of antiviral therapies.
International journal of medical and biological frontier. 02/2012;
-
Clinton D Kemp,
Mahadev Rao,
Sichuan Xi,
Suzanne Inchauste,
Haresh Mani,
Patricia Fetsch,
Armando Filie, Mary Zhang,
Julie A Hong,
Robert L Walker,
Yuelin J Zhu,
R Taylor Ripley,
Aarti Mathur,
Fang Liu,
Maocheng Yang,
Paul A Meltzer,
Victor E Marquez,
Assunta De Rienzo,
Raphael Bueno,
David S Schrump
[show abstract]
[hide abstract]
ABSTRACT: Polycomb group (PcG) proteins are critical epigenetic mediators of stem cell pluripotency, which have been implicated in the pathogenesis of human cancers. This study was undertaken to examine the frequency and clinical relevance of PcG protein expression in malignant pleural mesotheliomas (MPM).
Microarray, quantitative reverse transcriptase PCR (qRT-PCR), immunoblot, and immunohistochemistry techniques were used to examine PcG protein expression in cultured MPM, mesothelioma specimens, and normal mesothelial cells. Lentiviral short hairpin RNA techniques were used to inhibit EZH2 and EED expression in MPM cells. Proliferation, migration, clonogenicity, and tumorigenicity of MPM cells either exhibiting knockdown of EZH2 or EED, or exposed to 3-deazaneplanocin A (DZNep), and respective controls were assessed by cell count, scratch and soft agar assays, and murine xenograft experiments. Microarray and qRT-PCR techniques were used to examine gene expression profiles mediated by knockdown of EZH2 or EED, or DZNep.
EZH2 and EED, which encode components of polycomb repressor complex-2 (PRC-2), were overexpressed in MPM lines relative to normal mesothelial cells. EZH2 was overexpressed in approximately 85% of MPMs compared with normal pleura, correlating with diminished patient survival. Overexpression of EZH2 coincided with decreased levels of miR-101 and miR-26a. Knockdown of EZH2 orEED, or DZNep treatment, decreased global H3K27Me3 levels, and significantly inhibited proliferation, migration, clonogenicity, and tumorigenicity of MPM cells. Common as well as differential gene expression profiles were observed following knockdown of PRC-2 members or DZNep treatment.
Pharmacologic inhibition of PRC-2 expression/activity is a novel strategy for mesothelioma therapy.
Clinical Cancer Research 01/2012; 18(1):77-90. · 7.74 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Cancer-testis antigens (CTA), such as NY-ESO-1, MAGE-A1, and MAGE-A3, are immunogenic proteins encoded by genes, which are normally expressed only in male germ cells but are activated by ill-defined epigenetic mechanisms in human tumors, including lung cancers. Previously, we reported induction of these CTAs in cancer cells, but not normal cells, by DNA-demethylating agents and histone deacetylase inhibitors using clinically achievable exposure conditions. In the present study, we evaluated chromatin alterations associated with repression/activation of cancer-testis genes in lung cancer cells to further develop gene-induction regimens for cancer immunotherapy. Repression of NY-ESO-1, MAGE-A1, and MAGE-A3 coincided with DNA hypermethylation, recruitment, and binding of polycomb-group proteins, and histone heterochromatin modifications within the promoters of these genes. Derepression coincided with DNA demethylation, dissociation of polycomb proteins, and presence of euchromatin marks within the respective promoters. Short hairpin RNAs were used to inhibit several histone methyltransferases (KMT) and histone demethylases (KDM) that mediate histone methylation and repress gene expression. Knockdown of KMT6, KDM1, or KDM5B markedly enhanced deoxyazacytidine (DAC)-mediated activation of these cancer-testis genes in lung cancer cells. DZNep, a pharmacologic inhibitor of KMT6 expression, recapitulated the effects of KMT6 knockdown. Following DAC-DZNep exposure, lung cancer cells were specifically recognized and lysed by allogeneic lymphocytes expressing recombinant T-cell receptors recognizing NY-ESO-1 and MAGE-A3. Combining DNA-demethylating agents with compounds, such as DZNep, that modulate histone lysine methylation may provide a novel epigenetic strategy to augment cancer-testis gene expression as an adjunct to adoptive cancer immunotherapy.
Cancer Research 06/2011; 71(12):4192-204. · 7.86 Impact Factor
-
Sichuan Xi,
Maocheng Yang,
Yongguang Tao,
Hong Xu,
Jigui Shan,
Suzanne Inchauste, Mary Zhang,
Leandro Mercedes,
Julie A Hong,
Mahadev Rao,
David S Schrump
[show abstract]
[hide abstract]
ABSTRACT: Limited information is available regarding mechanisms by which miRNAs contribute to pulmonary carcinogenesis. The present study was undertaken to examine expression and function of miRNAs induced by cigarette smoke condensate (CSC) in normal human respiratory epithelia and lung cancer cells.
Micro-array and quantitative RT-PCR (qRT-PCR) techniques were used to assess miRNA and host gene expression in cultured cells, and surgical specimens. Software-guided analysis, RNA cross-link immunoprecipitation (CLIP), 3' UTR luciferase reporter assays, qRT-PCR, focused super-arrays and western blot techniques were used to identify and confirm targets of miR-31. Chromatin immunoprecipitation (ChIP) techniques were used to evaluate histone marks and transcription factors within the LOC554202 promoter. Cell count and xenograft experiments were used to assess effects of miR-31 on proliferation and tumorigenicity of lung cancer cells.
CSC significantly increased miR-31 expression and activated LOC554202 in normal respiratory epithelia and lung cancer cells; miR-31 and LOC554202 expression persisted following discontinuation of CSC exposure. miR-31 and LOC554202 expression levels were significantly elevated in lung cancer specimens relative to adjacent normal lung tissues. CLIP and reporter assays demonstrated direct interaction of miR-31 with Dickkopf-1 (Dkk-1) and DACT-3. Over-expression of miR-31 markedly diminished Dkk-1 and DACT3 expression levels in normal respiratory epithelia and lung cancer cells. Knock-down of miR-31 increased Dkk-1 and DACT3 levels, and abrogated CSC-mediated decreases in Dkk-1 and DACT-3 expression. Furthermore, over-expression of miR-31 diminished SFRP1, SFRP4, and WIF-1, and increased Wnt-5a expression. CSC increased H3K4Me3, H3K9/14Ac and C/EBP-β levels within the LOC554202 promoter. Knock-down of C/EBP-β abrogated CSC-mediated activation of LOC554202. Over-expression of miR-31 significantly enhanced proliferation and tumorigenicity of lung cancer cells; knock-down of miR-31 inhibited growth of these cells.
Cigarette smoke induces expression of miR-31 targeting several antagonists of cancer stem cell signaling in normal respiratory epithelia and lung cancer cells. miR-31 functions as an oncomir during human pulmonary carcinogenesis.
PLoS ONE 01/2010; 5(10):e13764. · 4.09 Impact Factor
